{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:45:27Z","timestamp":1794865527958,"version":"4.9.1"},"reference-count":49,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swedish government"},{"DOI":"10.13039\/501100009230","name":"county council of Uppsala","doi-asserted-by":"publisher","award":["46928"],"award-info":[{"award-number":["46928"]}],"id":[{"id":"10.13039\/501100009230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010805","name":"Medical Research Council of Southeast Sweden","doi-asserted-by":"publisher","award":["FORSS-981716"],"award-info":[{"award-number":["FORSS-981716"]}],"id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>GH excess and elevated IGF-1 in acromegaly are considered to promote cancer development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate cancer incidence and outcome in patients with acromegaly in relation to biochemical control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Matched cohort study in patients with acromegaly diagnosed from 1991 to 2018 and 10 controls per case from the Swedish population. Cancer diagnoses and fatalities were obtained from the Swedish Pituitary and National Patient Registers. Adjusted hazard ratio (HR) and 95% confidence intervals (CIs) for cancer incidence and death were estimated using a Cox proportional hazard regression model adjusted for age, sex, and comorbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 1035 patients with acromegaly (49.5% female; median age 52.0 years) and 10 261 matched controls. Patients had higher adjusted HR (95% CI) for all cancer (1.28, 1.11-1.49), colorectal cancer (1.84, 1.28-2.64), lung cancer (1.95, 1.22-3.11), hematologic cancer (1.68, 1.03-2.73), and breast cancer in women (1.46, 1.02-2.11) from 5 years before acromegaly diagnosis. Second cancers after diagnosis tended to be increased (1.54, 0.98-2.44). Death from cancer was only significantly elevated in patients 40 to 60 years of age (1.48, 1.19-1.85). Patients with persistently elevated IGF-1 had a higher overall mortality rate (1.50, 1.10-2.01) but no increase in cancer incidence or cancer-related mortality compared to biochemically controlled patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This nationwide, matched cohort study showed an increased risk of cancer in patients with acromegaly, underscoring the importance of vigilance for early signs of cancer after acromegaly diagnosis. Biochemical control had minor effects on increased cancer development, indicating an effect beyond GH hypersecretion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag137","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:47:39Z","timestamp":1774615659000},"page":"e2135-e2145","source":"Crossref","is-referenced-by-count":4,"title":["Acromegaly is associated with an increased incidence of primary malignant tumors: data from a national study in Sweden"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7630-3991","authenticated-orcid":false,"given":"Erika","family":"Tsatsaris","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Endocrinology and Mineral Metabolism, Uppsala University Hospital, Uppsala University , Uppsala SE-751 85 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3598-4155","authenticated-orcid":false,"given":"Jonas","family":"Rob\u00e8rt","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology in Link\u00f6ping and Norrk\u00f6ping, and Department of Health, Medicine and Caring Sciences, Link\u00f6ping University , Link\u00f6ping SE-581 83 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4844-8336","authenticated-orcid":false,"given":"Pia","family":"Burman","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5ne University Hospital Malm\u00f6, Lund University , Malm\u00f6 SE-205 02 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2488-0375","authenticated-orcid":false,"given":"Katarina","family":"Berinder","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Karolinska University Hospital , Stockholm SE-171 76 ,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm SE-171 76 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-6234","authenticated-orcid":false,"given":"Lorenza","family":"Bonelli","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5ne University Hospital Malm\u00f6, Lund University , Malm\u00f6 SE-205 02 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6471-9503","authenticated-orcid":false,"given":"Per","family":"Dahlqvist","sequence":"additional","affiliation":[{"name":"Department of Public Health and Clinical Medicine, Ume\u00e5 University , Ume\u00e5 SE-901 87 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-1927","authenticated-orcid":false,"given":"Charlotte","family":"H\u00f6ybye","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Karolinska University Hospital , Stockholm SE-171 76 ,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm SE-171 76 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-9492","authenticated-orcid":false,"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sahlgrenska University Hospital , Gothenburg SE-413 45 ,","place":["Sweden"]},{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg , Gothenburg SE-413 45 ,","place":["Sweden"]},{"name":"Wallenberg Center for Molecular and Translational Medicine, University of Gothenburg , Gothenburg SE-413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9501-6763","authenticated-orcid":false,"given":"Konstantina","family":"Vouzouneraki","sequence":"additional","affiliation":[{"name":"Department of Public Health and Clinical Medicine, Ume\u00e5 University , Ume\u00e5 SE-901 87 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-7695","authenticated-orcid":false,"given":"Anna-Karin","family":"\u00c5kerman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, \u00d6rebro University Hospital , \u00d6rebro SE-701 82 ,","place":["Sweden"]},{"name":"Faculty of Health and Medical Sciences, \u00d6rebro University , \u00d6rebro SE-701 82 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8732-7361","authenticated-orcid":false,"given":"Bertil","family":"Ekman","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology in Link\u00f6ping and Norrk\u00f6ping, and Department of Health, Medicine and Caring Sciences, Link\u00f6ping University , Link\u00f6ping SE-581 83 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-5193","authenticated-orcid":false,"given":"Britt Ed\u00e9n","family":"Engstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Endocrinology and Mineral Metabolism, Uppsala University Hospital, Uppsala University , Uppsala SE-751 85 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"6","key":"2026081219565647300_dgag137-B1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/cen.14828","article-title":"The prevalence of acromegaly is higher than previously reported: changes over a three-decade period","volume":"97","author":"Aagaard","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026081219565647300_dgag137-B2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-21-0729","article-title":"Long-term outcomes of patients with acromegaly: a report from the Swedish pituitary register","volume":"186","author":"Arnard\u00f3ttir","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026081219565647300_dgag137-B3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40618-023-02217-x","article-title":"Establishing a valid cohort of patients with acromegaly by combining the national patient register with the Swedish pituitary register","volume":"47","author":"Robert","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026081219565647300_dgag137-B4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"issue":"24","key":"2026081219565647300_dgag137-B5","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"2026081219565647300_dgag137-B6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ecl.2007.10.002","article-title":"Acromegaly","volume":"37","author":"Ben-Shlomo","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"2026081219565647300_dgag137-B7","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1210\/clinem\/dgac400","article-title":"Effect of diabetes on morbidity and mortality in patients with acromegaly","volume":"107","author":"Esposito","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026081219565647300_dgag137-B8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12020-018-1694-1","article-title":"Temporal relationship of sleep apnea and acromegaly: a nationwide study","volume":"62","author":"Vouzouneraki","year":"2018","journal-title":"Endocrine"},{"issue":"Suppl 5","key":"2026081219565647300_dgag137-B9","first-page":"166","article-title":"Excess mortality in acromegaly","volume":"68","author":"Holdaway","year":"2007","journal-title":"Horm Res"},{"issue":"1","key":"2026081219565647300_dgag137-B10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026081219565647300_dgag137-B11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"9418","key":"2026081219565647300_dgag137-B12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"2026081219565647300_dgag137-B13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2010.171","article-title":"Growth hormone, the insulin-like growth factor axis, insulin and cancer risk","volume":"7","author":"Clayton","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2026081219565647300_dgag137-B14","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/jc.2017-02457","article-title":"Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature","volume":"103","author":"Dal","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026081219565647300_dgag137-B15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12020-022-03275-6","article-title":"Trends in incidence and mortality risk for acromegaly in Norway: a cohort study","volume":"80","author":"Falch","year":"2023","journal-title":"Endocrine"},{"issue":"7","key":"2026081219565647300_dgag137-B16","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/jc.2004-1381","article-title":"A nationwide survey of mortality in acromegaly","volume":"90","author":"Kauppinen-M\u00e4kelin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026081219565647300_dgag137-B17","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2026081219565647300_dgag137-B18","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.14.3484","article-title":"Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis","volume":"14","author":"Rokkas","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"9","key":"2026081219565647300_dgag137-B19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-16-0553","article-title":"Acromegaly is associated with increased cancer risk: a survey in Italy","volume":"24","author":"Terzolo","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2026081219565647300_dgag137-B20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF03343997","article-title":"Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study","volume":"25","author":"Gasperi","year":"2002","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2026081219565647300_dgag137-B21","doi-asserted-by":"crossref","first-page":"e88787","DOI":"10.1371\/journal.pone.0088787","article-title":"Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly: meta-analysis and systematic review","volume":"9","author":"Wolinski","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2026081219565647300_dgag137-B22","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-16-0178","article-title":"Acromegaly and cancer: an old debate revisited","volume":"175","author":"Boguszewski","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026081219565647300_dgag137-B23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish acromegaly registry (Registro Espanol de Acromegalia, REA)","volume":"151","author":"Mestron","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026081219565647300_dgag137-B24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.32808","article-title":"Hormone-related diseases and prostate cancer: an English national record linkage study","volume":"147","author":"Watts","year":"2020","journal-title":"Int J Cancer"},{"issue":"8","key":"2026081219565647300_dgag137-B25","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group","volume":"83","author":"Orme","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026081219565647300_dgag137-B26","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1210\/jc.2015-2372","article-title":"The incidence of cancer among acromegaly patients: results from the German acromegaly registry","volume":"100","author":"Petroff","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11\/12","key":"2026081219565647300_dgag137-B27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-2004-814150","article-title":"Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications","volume":"35","author":"Renehan","year":"2003","journal-title":"Horm Metab Res"},{"issue":"3","key":"2026081219565647300_dgag137-B28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081219565647300_dgag137-B29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/EJE-18-0015","article-title":"Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study","volume":"178","author":"Esposito","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026081219565647300_dgag137-B30","doi-asserted-by":"crossref","first-page":"102914","DOI":"10.1016\/j.arcmed.2023.102914","article-title":"Acromegaly and cancer: an update","volume":"54","author":"Danilowicz","year":"2023","journal-title":"Arch Med Res"},{"issue":"1","key":"2026081219565647300_dgag137-B31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish cancer register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"issue":"6","key":"2026081219565647300_dgag137-B32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-20-0019","article-title":"Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality","volume":"182","author":"Esposito","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026081219565647300_dgag137-B33","doi-asserted-by":"crossref","first-page":"e097804","DOI":"10.1136\/bmjopen-2024-097804","article-title":"Estimating diagnostic delay in patients with pituitary adenomas in Sweden: a cross-sectional study","volume":"15","author":"Forsgren","year":"2025","journal-title":"BMJ Open"},{"issue":"5","key":"2026081219565647300_dgag137-B34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1210\/clinem\/dgae469","article-title":"Prospective, longitudinal study of cancer predictors and rates in a New York City cohort of 598 patients with acromegaly","volume":"110","author":"Freda","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026081219565647300_dgag137-B35","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EO-21-0033","article-title":"Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?","volume":"2","author":"Pekic","year":"2022","journal-title":"Endocr Oncol"},{"issue":"1","key":"2026081219565647300_dgag137-B36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11154-007-9063-z","article-title":"Acromegaly: re-thinking the cancer risk","volume":"9","author":"Loeper","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"2026081219565647300_dgag137-B37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11102-017-0789-7","article-title":"The genetic background of acromegaly","volume":"20","author":"Gadelha","year":"2017","journal-title":"Pituitary"},{"issue":"08","key":"2026081219565647300_dgag137-B38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/a-1143-5930","article-title":"Clinical and molecular update on genetic causes of pituitary adenomas","volume":"52","author":"Vasilev","year":"2020","journal-title":"Horm Metab Res"},{"issue":"1","key":"2026081219565647300_dgag137-B39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12020-022-03282-7","article-title":"Follow, consider, and catch: second primary tumors in acromegaly patients","volume":"80","author":"Oguz","year":"2023","journal-title":"Endocrine"},{"issue":"12","key":"2026081219565647300_dgag137-B40","first-page":"3487","article-title":"Incidence of benign and malignant tumors in patients with acromegaly is increased: a nationwide population-based study","volume":"106","author":"Esposito","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026081219565647300_dgag137-B41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ejendo\/lvaf029","article-title":"Acromegaly and the risk of cancer: a nationwide population-based cohort study in Korea","volume":"192","author":"Kim","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081219565647300_dgag137-B42","doi-asserted-by":"crossref","first-page":"e240087","DOI":"10.1530\/ERC-24-0087","article-title":"Increased cancer risk in a cohort of patients with acromegaly in Israel","volume":"32","author":"Duskin-Bitan","year":"2025","journal-title":"Endocr Relat Cancer"},{"key":"2026081219565647300_dgag137-B43","doi-asserted-by":"crossref","first-page":"924952","DOI":"10.3389\/fendo.2022.924952","article-title":"Acromegaly and colorectal neoplasm: an update","volume":"13","author":"Kasuki","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"2026081219565647300_dgag137-B44","doi-asserted-by":"crossref","first-page":"e0285335","DOI":"10.1371\/journal.pone.0285335","article-title":"Risk of cancer in acromegaly patients: an updated meta-analysis and systematic review","volume":"18","author":"Xiao","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"2026081219565647300_dgag137-B45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","article-title":"Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984","volume":"223","author":"Bengtsson","year":"1988","journal-title":"Acta Med Scand"},{"issue":"7","key":"2026081219565647300_dgag137-B46","doi-asserted-by":"crossref","first-page":"110137","DOI":"10.1016\/j.isci.2024.110137","article-title":"Excess endocrine growth hormone in acromegaly promotes the aggressiveness and metastasis of triple-negative breast cancer","volume":"27","author":"Kang","year":"2024","journal-title":"iScience"},{"key":"2026081219565647300_dgag137-B47","doi-asserted-by":"crossref","first-page":"1093942","DOI":"10.3389\/fendo.2022.1093942","article-title":"Sub-macroscopic skin presentation of acromegaly and effect of pituitary tumor surgery: a study using dermatoscopy and ultra-high-frequency ultrasound","volume":"13","author":"Guo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026081219565647300_dgag137-B48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-12-0084","article-title":"Predictors of morbidity and mortality in acromegaly: an Italian survey","volume":"167","author":"Arosio","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026081219565647300_dgag137-B49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cen.15060","article-title":"Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels: retrospective analysis from the UK acromegaly register 1970-2016","volume":"100","author":"Orme","year":"2024","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag137\/67680738\/dgag137.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/9\/e2135\/67680738\/dgag137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/9\/e2135\/67680738\/dgag137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:57:14Z","timestamp":1786579034000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/9\/e2135\/8565929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,3,30]]},"published-print":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag137","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,3,30]]}}}